Ruxolitinib (Jakavi®)
- Traffic LightRed
- BNF8.1.5
- Licensed IndicatorsMyelofibrosis, either primary in origin or following other related disorders such as polycythaemia
- ReferenceAPC Dec 12
- Criteria
- ProvisionalYes
Do you want to add this to your CPD record?
Did you find this page helpful?